Investors should monitor the AGM for any unexpected commentary on funding, clinical progress, or governance, but this filing itself contains no material information. The prior bearish context from the 20-F remains relevant—funding risk and going concern uncertainty persist.
Price Chart
Executive Summary
Innate Pharma announced the date and logistics for its 2026 Annual General Meeting of shareholders, scheduled for May 21, 2026, including registration details, voting procedures, and a live webcast. This is a routine administrative filing with no new financial or operational updates.
Key Facts
- Annual General Meeting (AGM) set for May 21, 2026, at company headquarters in Marseille.
- Meeting agenda and resolutions were published in the French BALO on April 13, 2026.
- Shareholders must register shares by May 14, 2026, to attend; written questions due by May 15, 2026.
- AGM will be webcast live; laboratory tour offered for shareholders on the same day.
- No material financial or clinical updates provided in this filing.
Financial Impact
No financial impact disclosed.
Risk Factors
- Continued risk to going concern status without near-term financing, as highlighted in the prior 20-F filing.
- Potential for negative shareholder sentiment or questions at the AGM regarding cash runway and strategic direction.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001628280-26-024819 |
| Document: a6k-iphx260413.htm | 0001628280-26-024819 |
| Document: 0001628280-26-024819-index-headers.html | 0001628280-26-024819 |
| Document: 0001628280-26-024819-index.html | 0001628280-26-024819 |
| Document: 0001628280-26-024819.txt | 0001628280-26-024819 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
May 19, 2026 23w ago | 6-K | $2.25 $1.65 | ▼ −26.67% | ▼ −32.96% | $1.51 (−32.93%) |
May 13, 2026 23w ago | 6-K | $1.50 $1.65 | ▼ −10.00% | ▼ −5.56% | $1.51 (−0.60%) |
May 6, 2026 24w ago | 6-K | $1.50 $1.65 | ▲ +10.00% | ▲ +7.94% | $1.51 (+0.60%) |
Apr 23, 2026 26w ago | 6-K | $1.50 $1.65 | ▲ +10.00% | ▲ +4.98% | $1.51 (+0.60%) |
Apr 17, 2026 27w ago | 6-K | $1.50 $1.65 | ▲ +10.00% | ▲ +3.86% | $1.51 (+0.60%) |
Apr 13, 2026 28w ago | 6-K | $1.37 $1.65 | ▲ +20.17% | ▲ +11.25% | $1.51 (+9.91%) |
Apr 13, 2026 28w ago | 6-K | $1.37 $1.65 | ▲ +20.17% | ▲ +11.25% | $1.51 (+9.91%) |
Apr 8, 2026 28w ago | 6-K | $1.37 $1.65 | ▲ +20.17% | ▲ +9.72% | $1.51 (+9.91%) |
Apr 3, 2026 29w ago | 6-K | $1.37 $1.65 | ▲ +20.17% | ▲ +6.71% | $1.51 (+9.91%) |
Apr 1, 2026 29w ago | 20-F | $1.37 $1.65 | ▼ −20.17% | ▼ −6.80% | $1.51 (−9.91%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers